Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01888 (long intergenic non-protein coding RNA 1888) is an annotated human long intergenic non-coding RNA (lincRNA) that does not encode a protein. LincRNAs are a subclass of long non-coding RNAs (lncRNAs), defined as autonomously transcribed RNAs longer than 200 nucleotides that do not overlap known protein-coding genes. LincRNAs are involved in various cellular processes, primarily through the regulation of gene expression, chromatin remodeling, and RNA stabilization. Many lincRNAs are tissue-specific and can impact neighboring gene function, but for most, including LINC01888, detailed biological roles remain uncharacterized. There are currently no drugs targeting LINC01888, and it is not recognized as a clinically actionable therapeutic target. Specific disease associations, biomarker utility, or safety considerations for LINC01888 have not been described in the available literature.
None (no drug mechanism of action described)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1888 (LINC01888).